AERPIO PHARMACEUTICALS INC (ARPO)
Institutional ownership reported to the SEC as of Q3 2021, across 12 quarters.
1
Reporting holders
$22.0K
Reported value
0.0%
Held as options
-37
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Truepoint, Inc. | $22.0K | 10,219 | 0.00% | 4q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2021 | 1 | $22.0K | 10,219 | 0 | 0 | 0 | 0.0% |
| Q2 2021 | 38 | $51.0M | 30,200,768 | 11 | 7 | 7 | 0.0% |
| Q1 2021 | 40 | $34.3M | 26,562,548 | 10 | 9 | 9 | 0.0% |
| Q4 2020 | 38 | $19.4M | 19,768,952 | 9 | 8 | 9 | 0.0% |
| Q3 2020 | 32 | $26.2M | 17,446,335 | 17 | 5 | 2 | 0.0% |
| Q2 2020 | 20 | $11.7M | 9,357,984 | 7 | 1 | 5 | 0.0% |
| Q1 2020 | 17 | $4.3M | 7,745,811 | 1 | 4 | 2 | 0.0% |
| Q4 2019 | 22 | $5.6M | 9,009,249 | 2 | 4 | 4 | 0.0% |
| Q3 2019 | 24 | $6.5M | 9,502,156 | 2 | 3 | 8 | 0.0% |
| Q2 2019 | 23 | $9.0M | 9,856,011 | 4 | 7 | 3 | 0.0% |
| Q1 2019 | 25 | $8.6M | 9,521,678 | 11 | 7 | 2 | 0.0% |
| Q4 2018 | 24 | $18.3M | 10,784,028 | 1 | 0 | 1 | 0.0% |